Prognostic Value of Early Postoperative Prostate-Specific Antigen for Oncological Outcomes After Radical Prostatectomy
Condition: Prostate Cancer (Post Prostatectomy), Prostate Cancer (Adenocarcinoma), Prostate Cancer (Diagnosis), Prostate Specific Antigen, Radical Prostatectomy
Study Type: Observational [Patient Registry]
Clinical Trials Identifier NCT 8-digits: NCT07516886
Sponsor: Lithuanian University of Health Sciences
Phase:
Eligibility:
- Age: minimum 18 Years maximum N/A
- Gender: Male
Inclusion Criteria:
- Patient is an adult biological male.
- Patient has morphologically confirmed and untreated prostate cancer.
- Patient who will be treated with open, laparoscopic or robot-assisted laparoscopic radical prostatectomy.
- Patient is informed about this observational study and has signed the informed consent form.
Exclusion Criteria:
- Patient has radiologically of morphologically confirmed prostate cancer metastases before the operation.
- Patient received neoadjuvant prostate cancer treatment.
- Patient is set to receive adjuvant treatment.
- Patient has any contraindications for the operation.
View trial on ClinicalTrials.gov